12월 13, 2019 / Yeungnam University, etc. / Scientific Reports

Text / 우팅야오

Just as the daily lives of all human beings are upset by the 2019 novel coronavirus, there are still many viruses that are incurable. Dengue fever virus that infects humans through mosquito bites is one of them.

Like all viruses, the dengue virus that infects humans through mosquito bites also uses cells to reproduce the next generation. Therefore, how to interfere with the replication process of the virus in cells has become the main countermeasure for the development of related drugs.

현재, many studies have targeted the dengue virus NS2B-NS3 protease, because it is an indispensable element for the dengue virus to complete the replication process. Without its role, the virus cannot reproduce itself to infect other cells.

According to a study published in “Scientific Reports” in December 2019, the Biotechnology Institute of Yeungnam University in South Korea and teams from India and Turkey screened 22 kinds of triterpenoids from the fruiting body of영지버섯 and found that four of them showed potential inhibition of NS2B-NS3 protease activity.

By the use of in vitro experiments to simulate the way the virus infects cells in the body, the researchers further evaluated two kinds of영지버섯 triterpenoids :

The researchers first cultured the dengue virus type 2 (DENV-2, the type most likely to cause severe illness) with human cells for 1 시간, and then treated them with different concentrations (25 또는 50 μM) ~의영지버섯 triterpenoids for 1 시간. 후에 24 hours, they analyzed the ratio of cells infected by the virus.

The results showed that ganodermanontriol can reduce the cell infection rate by approximately 25% (25μM) 또는 45% (50μM) while the relative ganoderic acid C2 does not have much inhibitory effect.

The results of this research provide us with another antiviral possibility of영지버섯 and also provide a new opportunity for the treatment of dengue fever, for which there is no specific drug available.

The above is a schematic diagram of the steps of screening candidate drugs to inhibit the dengue virus from영지버섯 triterpenoids with NS2B-NS3 protease as the target. The statistical chart at the bottom right shows the inhibitory rate of ganodermanontriol on cells infected with dengue fever virus type 2.

[원천] Bharadwaj S, 외. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease. Sci Rep. 2019 Dec 13;9(1):19059. doi: 10.1038/s41598-019-55723-5.

끝

저자 소개 / 씨. 우팅야오
Wu Tingyao has been reporting on first-hand Ganoderma lucidum information since 1999. She is the author of Healing with Ganoderma (4월 인민의학출판사에 게재 2017).

★ 이 글은 저자의 단독 승인 하에 게재되었습니다.

★ 위 작품은 복제할 수 없습니다, 저작자의 허락 없이 발췌하거나 다른 방법으로 사용한 경우

★ Violation of the above statement, the author will pursue its related legal responsibilities

★ 이 기사의 원문은 Wu Tingyao가 중국어로 작성하고 Alfred Liu가 영어로 번역했습니다.. 번역 내용에 차이가 있는 경우 (English) 그리고 원본 (중국인), 원래 중국어가 우선합니다. 독자들이 궁금한 점이 있으면, 원작자에게 연락주세요, 양. 우팅야오.